Latest News about Biotech
Recent news which mentions Biotech
Alterity's Stock Is Trading Higher As ATH434 Preserves Neurons, Motor Performance In Animal Model With Neurodegenerative Disorder
Today 9:25 EDT
Tickers
ATHE
From Benzinga
Why Bionano Genomics, Ocugen Are Rallying Today
Today 9:23 EDT
From Benzinga
Brii Biosciences, Vir Biotech, VBI Vaccines Start Combination Therapy Hepatitis B Study
Today 8:50 EDT
From Benzinga
House Democrats Investigating Emergent BioSolutions' Vaccine Contracts, Call On Execs To Testify
Today 7:52 EDT
From Benzinga
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Today 7:31 EDT
From Benzinga
Kindred's New IL-31 Antibody Shows Improved Shelf Life In PK Study For Canine Dermatitis
Today 6:38 EDT
Tickers
KIN
From Benzinga
Roche Backs 2021 Outlook Despite Lackluster Q1 Performance In Pharmaceuticals Division
Today 6:32 EDT
From Benzinga
Johnson & Johnson Set To Resume COVID-19 Vaccine Rollout In Europe — With A Warning On The Label
Today 2:06 EDT
From Benzinga
From Issuewire
From OTC
Castle Creek Biosciences names new CEO
April 20, 2021
From Business Journals
Hoth Therapeutics' mRNA Frame Shifting Therapeutic Inhibits Tumor Growth, Animal Study Shows
April 20, 2021
Tickers
HOTH
From Benzinga
NEUROONE BEGINS 2021 BY HITTING FIRST PERFORMANCE MILESTONE AND CLOSES LUCRATIVE PRIVATE PLACEMENT
April 20, 2021
From Benzinga
ADVAXIS MAKING BOLD STEPS IN NEW CANCER STUDIES AND AGREEMENT WITH COLUMBIA UNIVERSITY
April 20, 2021
Tickers
ADXS
From Benzinga
Y-mAbs Asked To Submit Additional Granularity Of Data For Omburtamab In Nerve Tissue Cancer
April 20, 2021
Tickers
YMAB
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Market Action
MARKET NEWS
Home | Individual investors | Institutional investors | Find an advisor | Opportunities at Winslow | About | News | Contact | Mobile | Site map
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.
Privacy | Legal notices | Copyright 2021 Winslow, Evans & Crocker
Investing involves risk including loss of principal. Securities and Variable Insurance Products offered through National Securities Corporation, member FINRA/ SIPC. Fee-based investment advisory services offered through National Asset Management, an SEC registered investment advisor. Insurance products, including fixed indexed annuities offered through National Insurance Corporation.